Difficulty: Medium
Average Score: 62%
Practice
Which of the following mood stabilizers would be most appropriate in a patient with liver disease?
Correct answer
A
Rationale
In a patient with liver disease, the most appropriate mood stabilizer would be lithium (Option A). Lithium is primarily eliminated through the kidneys and does not undergo hepatic metabolism, making it the safest choice in individuals with liver impairment.
Valproic acid (Option B) and carbamazepine (Option C) are both metabolized in the liver, which can pose a risk of drug accumulation and toxicity in patients with liver disease. Therefore, these options are not ideal for individuals with compromised liver function.
By understanding the pharmacokinetics of these medications, healthcare providers can make informed decisions when selecting appropriate treatments for patients with liver disease. It is crucial for healthcare professionals to consider individual patient factors, such as comorbidities, when prescribing medications to ensure patient safety and treatment efficacy.
Valproic acid (Option B) and carbamazepine (Option C) are both metabolized in the liver, which can pose a risk of drug accumulation and toxicity in patients with liver disease. Therefore, these options are not ideal for individuals with compromised liver function.
By understanding the pharmacokinetics of these medications, healthcare providers can make informed decisions when selecting appropriate treatments for patients with liver disease. It is crucial for healthcare professionals to consider individual patient factors, such as comorbidities, when prescribing medications to ensure patient safety and treatment efficacy.